Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by cytochromeon May 09, 2016 2:23pm

135 Views

Post# 24854818

RE:TLC-2000 exploits the most optimal therapeutic wavelength

Bencro - yes I know there is some research that has used superpulsed 904/5 nm wavelengths. But the VAST majority have not. A simple search of LLLT + superpulsed finds 10 research papers. You really don't know what you are talking about. Why don;t you spend 30 min on PubMed and start looking at the commonly used wavelengths used and then get back to me.

Bullboard Posts

Sony’s Alpha 1 II: A new professional photography standard?